Evidence map›Paper›PMID 23265411›Full record

ReviewHearing research2013

Gene therapy for the inner ear.

Hideto Fukui, Yehoash Raphael

Open access · greenAbstract readReview
In one paragraph

Review in Hearing research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The use of nonhuman primates in studies of noise injury and treatment.The Journal of the Acoustical Society of America · 2019
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Hearing Loss in Adults.The New England journal of medicine · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Hideto FukuiKresge Hearing Research Institute, Department of Otolaryngology, University of Michigan, 1150 West Medical Center Dr., Ann Arbor, MI 48109-5648, USA.
Yehoash Raphael
Kansai Medical University · JPUniversity of Michigan–Ann Arbor · US

Funding

Scientific Synergy CoreP30DC005188 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DOLAN, DAVID FRANCIS · 2002 to 2016
$10.3M
Advanced Research Training in OtolaryngologyT32DC005356 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CORFAS, GABRIEL · 2002 to 2021
$3.5M
SCAR FORMATION IN DAMAGED AND REGENERATING COCHLEAER01DC001634 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAPHAEL, YEHOASH · 1993 to 2009
$2.4M
Cochlear Implants in Reinnervated EarsR01DC010412 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAPHAEL, YEHOASH · 2010 to 2014
$2.2M
Acoustic and electrical hearing after Atoh1 treatmentR01DC007634 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PFINGST, BRYAN E · 2006 to 2010
$1.6M
Integrating cells into the auditory epithelium of deaf earsR21DC011631 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAPHAEL, YEHOASH · 2012 to 2013
$418k
Acoustic and electrical hearing after Math1 treatmentR55DC007634 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PFINGST, BRYAN E · 2005 to 2005
$100k
NIDCD NIH HHS DC-007634NIDCD NIH HHS DC-010412NIDCD NIH HHS P30 DC005188NIDCD NIH HHS P30 DC-05188NIDCD NIH HHS R01 DC001634NIDCD NIH HHS R01 DC007634NIDCD NIH HHS R01 DC010412NIDCD NIH HHS R21 DC011631NIDCD NIH HHS R55 DC007634NIDCD NIH HHS T32 DC-005356NIDCD NIH HHS T32 DC005356
6 · The paper itself

Abstract

Animal studies on inner ear development, repair and regeneration provide understanding of molecular pathways that can be harnessed for treating inner ear disease. Use of transgenic mouse technology, in particular, has contributed knowledge of genes that regulate development of hair cells and innervation, and of molecular players that can induce regeneration, but this technology is not applicable for human treatment, for practical and ethical reasons. Therefore other means for influencing gene expression in the inner ear are needed. We describe several gene vectors useful for inner ear gene therapy and the practical aspects of introducing these vectors into the ear. We then review the progress toward using gene transfer for therapies in both auditory and balance systems, and discuss the technological milestones needed to advance to clinical application of these methods.

Indexed as

AnimalsDisease Models, AnimalEar, InnerGene ExpressionGene Expression ProfilingGene Expression RegulationGenetic TherapyGenetic VectorsHearing Loss, SensorineuralHumansLabyrinth DiseasesMiceMice, TransgenicNerve RegenerationNeuronsSignal Transduction

Identifiers

PMID23265411
PMCPMC3594056
OpenAlexW2000747235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.